Stryker’s purchase of Cerus Endovascular probed by UK CMA
MLex Summary: Stryker's plan to acquire Cerus Endovascular is being probed by the UK competition regulator. The watchdog will decide by April 24 whether the deal, which combines medical technology companies,...To view the full article, register now.
Already a subscriber? Click here to view full article